Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHONY.L Regulatory News (HONY)

  • There is currently no data for HONY

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monthly Update – October 2020

1 Dec 2020 07:01

RNS Number : 0189H
Honeycomb Investment Trust PLC
01 December 2020
 

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA (OTHER THAN THE UNITED KINGDOM), CANADA, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL

1st December 2020

Honeycomb Investment Trust plc

Honeycomb Investment Trust plc (the "Company") announces that the investment manager's monthly factsheet for October 2020 is now available on its website at http://www.honeycombplc.com. The text of the factsheet has been reproduced below.

October Factsheet

Honeycomb Investment Trust plc (the "Company" or "HONY") delivered a NAV return of 0.58% for the month, which is equivalent to 6.8% per annum.

Portfolio Performance and Leverage

The portfolio continues to perform well with stable performance throughout the Covid period. This stability is driven by the Company's focus on credit investments secured on loan portfolios of non-bank lenders with strong downside protection from structural seniority and junior cash equity provided by the borrower. This first loss buffer provides a double layer of protection so that, on top of robust performance in the underlying portfolios, HONY returns are further insulated from defaults in the underlying loans and receivables.

Cash collections in HONY have been consistent throughout 2020 with £153m collected over the past 6 months vs £141m in the prior 6 months. The strong level of cash collection along with the low levels of new investments during the Covid period has meant that the investment portfolio has repaid down from £595m in February 2020 to a low £509m in August. This increased to £553m in October through drawdowns under existing investments and the completion of three new investments. The income generated by the Company is directly proportional to the size of the investment portfolio with the full benefit of new investments not recognized until the month after completion.

The Company has been careful in its deployment and is being highly selective in the new investments it makes. The pipeline of new opportunities is looking strong and the Company expects the investment assets to build back towards the £600m level over the coming months.

As mentioned in the September newsletter the Company extended its debt facilities in September and October with the maturities now falling in Q4 2022 and Q3 2023 meaning the Company has secured its financing facilities over the medium term. In addition, in November alongside increasing a senior facility secured on Coronavirus Business Interruption Loan Scheme ("CBILS") loans, the Company secured an attractively priced, term matched non-recourse SPV financing against the investment.

The total committed financing under these facilities is £360m. The total amounts drawn under these facilities at 31st October was £230m with the Company having £37m in cash. The net debt to equity was 53.3% and debt to equity was 63.6%. The Company's intention is to remain within the net debt to equity target of 50%-75% with a proportion of the revolving TOPCO facility being reserved as a liquidity buffer which is not forecast to be drawn. Both of the SPV facilities repay monthly and therefore reduce in size in line with the assets that support them.

The Company believes securing longer term larger facilities is a prudent approach as it provides a liquidity buffer for unforeseen circumstances, positions the company to take advantage of exceptional opportunities and means leverage is already secured in the event that the trust grows in the future without the need with further re-financings.

Buybacks

The Board have put in place an active buyback program throughout 2020 with the Company repurchasing 3,980,178 or 11.2% of the share capital. In October the Company repurchased 163,000 of its shares at an average price of 926.8p. On the 11th November the Company announced it had increased the size of this program with the Board stating its intention to continue until the share price is less than a 5% discount to NAV.

Portfolio Composition

The portfolio is well diversified with ~40 different investments across a variety of sectors and is well balanced across SME, Consumer and Property.

The portfolio is performing well with 88% being structurally secured with subordinated equity junior to the Company's position, insulating the Company from volatility in the performance of the underlying assets.

The remaining 12% consists of consumer direct unsecured loans and the equity positions. The consumer direct position has been in run off for the past 18+ months and the Manager accelerated the return of capital by selling £44.6m in August at a small premium to NAV. The loans are amortising and generating returns in line with target and the remaining exposure is expected to run off naturally in 12 months. The Manager is exploring options to accelerate the return of capital and will redeploy the proceeds in structurally secured loans.

The structurally secured portfolio is performing well with strong income, conservative LTVs and over collateralization.

The Company has just completed a £16m (day 1 amount) new investment supported by short term property loans where the Company has acquired a carefully selected portfolio of 17 loans from a development finance lender that are performing and seasoned. The loans are expected to deliver a 9% return and have an LTV of 59%.

 

This document is made available for information purposes only and does not contain any representations or constitute an offer to sell or the solicitation of an offer to acquire or subscribe for any securities of the Company. All investments are subject to risk. Prospective investors are advised to seek expert legal, financial, tax and other professional advice before making any investment decision. The value of investments may fluctuate and past performance is no guarantee of future results. 

For further information about this announcement please contact:

Pollen Street Capital - Investment Manager

Matthew Potter / Julian Dale: +44 (0)20 3728 6750

Liberum Capital Limited - Joint Broker

Chris Clarke / Louis Davies: +44 (0)20 3100 2000 

Cenkos Securities plc - Joint Broker

Justin Zawoda-Martin / Rob Naylor: +44 (0)20 7397 8900

Link Company Matters Limited - Corporate Secretary

Paul Johnston: +44 (0)20 7954 9552

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCEAFFEDFSEFAA
Date   Source Headline
7th Oct 20227:00 amRNSChange of Name
5th Oct 20225:11 pmRNSHolding(s) in Company
5th Oct 20225:11 pmRNSHolding(s) in Company
5th Oct 20225:07 pmRNSHolding(s) in Company
5th Oct 20225:04 pmRNSHolding(s) in Company
5th Oct 202212:01 pmRNSDirector/PDMR Shareholding
4th Oct 20226:23 pmRNSHolding(s) in Company
4th Oct 20225:44 pmRNSHolding(s) in Company
4th Oct 20225:10 pmRNSHolding(s) in Company
4th Oct 20224:53 pmRNSHolding(s) in Company
4th Oct 202212:07 pmRNSHolding(s) in Company
4th Oct 202211:29 amRNSHolding(s) in Company
30th Sep 20228:12 amRNSCompletion of the Combination with Pollen Street
26th Sep 20222:40 pmRNSPublication of a Prospectus
14th Sep 20224:44 pmRNSChange Of Latest DRIP Election Date
13th Sep 20227:45 amRNSHalf-year Report
6th Sep 20221:48 pmRNSDividend Declaration
6th Sep 20227:00 amRNSNAV and Monthly Update - July 2022
3rd Aug 20227:00 amRNSMonthly Update - June 2022
25th Jul 20227:00 amRNSAppointment of Corporate Broker
29th Jun 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
28th Jun 20227:00 amRNSNAV and Monthly Update - May 2022
22nd Jun 20224:12 pmRNSResult of AGM
22nd Jun 20227:00 amRNSTransaction in Own Shares & Total Voting Rights
17th Jun 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
1st Jun 20224:10 pmRNSResults of General Meeting
26th May 20227:00 amRNSNAV and Monthly Update – April 2022.
18th May 20224:22 pmRNSPosting of Annual Report and Notice of AGM
18th May 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
10th May 20222:36 pmRNSCircular and Notice of General Meeting
6th May 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
29th Apr 20227:00 amRNSShare Buyback Programme Extension
27th Apr 20227:00 amRNSMonthly Update - March 2022
26th Apr 20224:34 pmRNSDividend Declaration
7th Apr 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
25th Mar 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
21st Mar 20227:01 amRNSTransaction in Own Shares
21st Mar 20227:00 amRNSMonthly Update - February 2022
11th Mar 20223:21 pmRNSRussian Exposure
2nd Mar 20227:01 amRNSAnnual Financial Report
2nd Mar 20227:00 amRNSStatement re Share Buyback
2nd Mar 20227:00 amRNSCapital Markets Day
24th Feb 20227:00 amRNSNotice of upcoming Capital Markets Event
23rd Feb 20222:34 pmRNSDirector Declaration
23rd Feb 20222:28 pmRNSDividend Declaration
15th Feb 20227:00 amRNSHoneycomb combination with Pollen Street Capital
31st Jan 20227:00 amRNSMonthly Update - December 2021
23rd Dec 20217:00 amRNSNAV and Monthly Update - November 2021
24th Nov 20211:13 pmRNSDividend Declaration
23rd Nov 20217:00 amRNSNAV and Monthly Update - October 2021

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.